Allos Therapeutics, Inc. (NASDAQ:ALTH)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Recs

0
Player Avatar KimLanners (< 20) Submitted: 10/10/2011 10:30:08 AM : Underperform Start Price: $1.48 ALTH Score: -9.18

I say not possible.

Report this Post Reply

Featured Broker Partners


Advertisement